premature birth respiratory failure
Conditions
Interventions
None listed
Sponsors
Academisch Medisch Centrum
Eligibility
Age
2 Years to 11 Years
Inclusion criteria
Inclusion criteria: non-invasive respiratory support premature infants below 34 weeks of gestational age written informed consent
Exclusion criteria
Exclusion criteria: congenital anomalies of the thorax
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The effects of apnea/coffeine and dopram treatment/surfactant administration/positional changes on functional residual volume, tidal volume and ventilation distribution. | — |
Secondary
| Measure | Time frame |
|---|---|
| During the study, all patients will be monitored according to clinical protcol. Of the available parameters, the following will be registered: heart rate, breathing frequency, transcutaneous oxygen and carbondioxide tension, current non-invasive respiratory support pressure and fractional oxygen concentration (FiO2). Furthermore, patient caracteristics will be obtained like gestational age, birth weight, age and diagnosis. | — |
Countries
Netherlands
Outcome results
None listed